📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
0
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ABBV.
💹 Market Data
Market Cap$386.27B
Shares Outstanding1.77B
Float1.76B
Cash$9.39B
Debt$72.91B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 2.6% shares (2025Q4 vs prior)
4060 institutional holders · 1.42B shares
#1
VANGUARD GROUP INC
180.78M shares
#2
BlackRock, Inc.
151.17M shares
#3
STATE STREET CORP
80.94M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest20.91M
Days to Cover2.7
% of Float1.2%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Mar 06, 2026
4
INSIDER TRANSACTION
Mar 06, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ABBV
📊 ABBV FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ABBV Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.